Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Homestead, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Homestead, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Jupiter, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Jupiter, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Kissimee, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Kissimee, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Miami, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
New Port Richie, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
New Port Richie, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Orlando, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Tallahassee, FL
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Lawrenceville, GA
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Iowa City, IA
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
North Dartmouth, MA
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Therapeutics Site
mi
from
Minneapolis, MN
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Therapeutics Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
St. Louis, MO
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Bellevue, NE
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Omaha, NE
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Skillman, NJ
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Skillman, NJ
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Albuquerque, NM
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
New York, NY
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Charlotte, NC
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Raleigh, NC
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Winston-Salem, NC
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Cincinnati, OH
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Cincinnati, OH
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Middleburg Heights, OH
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Toledo, OH
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Oklahoma City, OK
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Eugene, OR
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Eugene, OR
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Medford, OR
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Portland, OR
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Providence, RI
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Providence, RI
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Warwick, RI
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Warwick, RI
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Rock Hill, SC
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Austin, TX
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Austin, TX
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Houston, TX
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Houston, TX
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Plano, TX
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Plano, TX
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Richmond, VA
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated:  9/23/2015
Oriel Investigative Site
mi
from
Tacoma, WA
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
Clinical Endpoint Study of Salmeterol Xinafoate/Fluticasone Propionate Combination for Comparison of a Test and Reference Product in Patients With Asthma
Status: Enrolling
Updated: 9/23/2015
Oriel Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10426
mi
from
Mobile, AL
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10426
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 36
mi
from
Fresno, CA
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 36
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10147
mi
from
Long Beach, CA
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10147
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10133
mi
from
Denver, CO
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10133
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10528
mi
from
Waterbury, CT
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10528
mi
from
Waterbury, CT
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 13
mi
from
Clearwater, FL
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 13
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 1345
mi
from
Miami, FL
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 1345
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10168
mi
from
Lawrenceville, GA
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10168
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10113
mi
from
Metairie, LA
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10113
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 10164
mi
from
Bangor, ME
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 10164
mi
from
Bangor, ME
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site
mi
from
St. Louis, MO
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated:  9/24/2015
Teva Investigational Site 67
mi
from
Fort Mill, SC
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Status: Enrolling
Updated: 9/24/2015
Teva Investigational Site 67
mi
from
Fort Mill, SC
Click here to add this to my saved trials